`
`“—
`
`——
`
`Title of Invention:
`
`AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENT BY MAGNETIC
`FIELD
`
`
`
`——
`
`Payment information:
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`——
`
`
`
`
`
`- a
`
`Non Patent Literature
`
`NPL100_Uniunl_12_EFS.PDF C411015759167ea787bee4e96f792c890ec
`68b50
`
`Non Patent Literature
`
`NPL101_URBAN_MagnetoPhysi
`o_EFS.PDF
`
`1c9c1ecedOebc416191510c9d911f4d7271
`7eb88
`
`13519717
`
`Non Patent Literature
`
`NPL102_UROD|AGNOSTICCL|N|
`C.PDF
`
`aB746e8ee9a101979d2d305d094837dd36
`6e9b66
`
`7020250
`
`Non Patent Literature
`
`NPL103_USERGU|DE_MagVen.
`
`15f634defba90ffb7d27f5f8357cb4adb4b3 '
`4M
`
`4371278
`
`Non Patent Literature
`
`NPL104_USERGuide_Sa|us.PDF ce3f62192438233d6e23835b7833032db47
`351354
`
`13663888
`
`Document Descri
`
`tion
`
`p
`
`Non Patent Literature
`
`File Size(Bytes)/
`Message Digest
`10773878
`
`Pages
`Multi
`Part /.zip (if appl.)
`
`d8327356b1d8d6bc4f5749786e65c86c9ca
`aa9bf
`
`6084357
`
`-
`
`File Listing:
`
`Document
`Number
`
`.I
`
`a”.o qE W=- oE
`
`-
`
`a”.o qE W=- oE
`
`a”.c: .t53 W=- c:5!
`
`”.c: .t53 W=- c:5!
`
`- a
`
`”.c: .t53 W=- c:5!
`
`a”.c: .t53 W=- c:E!
`
`
`
`Non Patent Literature
`
`NPL105_Sa|usTa|ent_REMED.
`
`11930369
`
`cedfe647048b4da76c53367b8d99d4a9766
`aedbb
`
`Non Patent Literature
`
`NPL106_USERMANUAL_BTL—6O
`OO.PDF
`
`9968635
`
`442e9fe7db2015bbcc63b48438c77badbec
`63963
`
`2547178
`
`1848ebc2686082dbd79e2b98c71577ac6cl
`
`Non Patent Literature
`
`NPL107_UserMan_SALUS.PDF 3ddecc8e3f771d3c5029ea12bf301f0d334c
`07Gb
`
`Non Patent Literature
`
`NPL108_USERMANUAL_2014_
`7_EFS.PDF
`
`1ffb4193518447c483251bef7c6417a7e083
`0385
`
`2154032
`
`Non Patent Literature
`
`N PL109_Van_OperMan_BTL_2
`012_48_EFS.PDF
`
`d72f9701c317895c3218abe099e331c671e
`5301
`
`12560185
`
`Non Patent Literature
`
`NPL110_VenLeg_DelProm_24_
`EFS.PDF
`
`Non Patent Literature
`
`NPL1 11_VenLeg_UseMan_200
`9_49_EFS.PDF
`
`11629658
`
`f72793eb83bb63238e37ab14dcd4504d7a
`f87cb
`
`15582783
`
`
`
`Non Patent Literature
`
`NPL112_VenSwan_2_EFS.PDF
`
`1176680
`
`c03092f252e81e3639fcdd58568e37b8417
`23233
`
`Non Patent Literature
`
`NPL113_VenusFreez_2_EFS.
`
`1025752
`
`8423182303b928bf7dd3f73b6dae24d455f
`ee758
`
`520279
`
`Non Patent Literature
`
`NPL114_Verges.PDF
`
`397e0d3bf8103374c5e50fbe0500879437ff
`e580
`
`Non Patent Literature
`
`NPL115_WAS|LEWSK|_2012_4_
`EFS.PDF
`
`524be2f23bbf457c25bf35592d179e3678d I
`
`6950810
`
`4cae0
`
`Non Patent Literature
`
`NPL116_WEB_MD_NPL_EFS.
`
`Non Patent Literature
`
`NPL1 17_Zwave_Ver5_44_EFS.
`
`1969947
`
`5bc018024f8daa985ddde3cf4e3f0d6d2c6
`1950
`
`8999345
`
`d405b11223f028bb7763f74f5d237413d16
`25003
`
`5047004
`
`Non Patent Literature
`
`NPL118_ZELICKSON.PDF
`
`e193e690e8862a6cd47b57e8c1f6353e9ad
`
`
`
`Non Patent Literature
`
`NPL119_ZELTIQSys.PDF
`
`2d1f539a40384fc38e5faccf8837618f3ffeb .
`e
`
`19974954
`
`Non Patent Literature
`
`NPL120_ZERONA_3_EFS.PDF
`
`Non Patent Literature
`
`NPL121_ZERONA_2015_EFS.
`
`Transmittal Letter
`
`TransmittalForIDS—4387—OOSOO
`O4.PDF
`
`782143
`
`c01568741bd7ceeb7c3f31e06083f366462
`Odee
`
`765135
`
`3550df71c2d50393f94969de6dcccd84248 '
`353d
`
`268633
`
`072d303d55811156e5d0e4405f0b8cc3d95
`15717
`
`-
`
`Request for Continued Examination
`(RCE)
`
`2020—01—O8—RCE—4387—OOSOOO4.
`
`1349950
`
`b1f23062edadf84667eb2b532673833d2e9
`66e1d
`
`||||||H||||
`
`TrackOne Request
`
`Track—One—
`
`Request—4387—OOSOOO4.PDF
`
`9749a9bd36254d03e34752c13d9cee8375
`be064
`
`141097
`
`Transmittal Letter
`
`|DSPIeading_4387_OOSOOO4.
`
`3e2fea971da9bf50e508028929821001352
`29503
`
`144245
`
`
`
`Information Disclosure Statement (IDS)
`Form (5308)
`
`|DS—4387—OOSOOO4.pdf
`
`53bea4l 35791b300b74l643183e2dde26a
`80ee26
`
`4661 60
`
`Information:
`
`This is not an USPTO supplied IDS fillable form
`
`Fee Worksheet (SBO6)
`
`fee—info.pdf
`
`abaf9aee5e82062233636149384933 1 E7741
`33dl
`
`Information:
`
`Total Files Size (in bytes)
`
`171420958
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`the application.
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`
`